EurekaMag.com logo
+ Site Statistics
References:
53,214,146
Abstracts:
29,074,682
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

ROCK and cAMP promote lymphatic endothelial cell barrier integrity and modulate histamine and thrombin-induced barrier dysfunction



ROCK and cAMP promote lymphatic endothelial cell barrier integrity and modulate histamine and thrombin-induced barrier dysfunction



Lymphatic Research and Biology 9(1): 3-11



There is recent evidence that inflammatory signals can modulate lymphatic vessel permeability, but current understanding of the mechanisms regulating lymphatic endothelial barrier function is limited. The objectives of this study were to 1) investigate whether inflammatory mediators that increase microvascular permeability also cause barrier dysfunction of lymphatic endothelial cell monolayers, and 2) determine the roles of signaling pathways that affect intercellular junctions and cell contraction in lymphatic endothelial barrier function. Transendothelial electrical resistance (TER) of confluent adult human microlymphatic endothelial cells of dermal origin (HMLEC-d) served as an indicator of lymphatic endothelial barrier function. Human umbilical vein endothelial cells (HUVEC) were used to model blood-tissue barrier function. The inflammatory mediators histamine and thrombin each caused a decrease in TER of HMLEC-d and HUVEC monolayers, with notable differences between the two cell types. Treatment with 8-Br-cAMP enhanced HMLEC-d barrier function, which limited histamine and thrombin-induced decreases in TER. Blockade of myosin light chain kinase (MLCK) with ML-7 did not affect histamine or thrombin-induced decreases in TER. Treatment with the Rho kinase (ROCK) inhibitor Y-27632 caused a decrease in HMLEC-d barrier function. These data show that inflammatory mediators can cause lymphatic endothelial barrier dysfunction, although the responses are not identical to those seen with blood endothelial cells. ROCK and cAMP both promote lymphatic endothelial barrier function, however ROCK appears to also serve as a mediator of histamine and thrombin-induced barrier dysfunction.

(PDF same-day service: $19.90)

Accession: 055338096

Download citation: RISBibTeXText

PMID: 21417762

DOI: 10.1089/lrb.2010.0016



Related references

Endothelial Regulator of Calcineurin 1 Promotes Barrier Integrity and Modulates Histamine-Induced Barrier Dysfunction in Anaphylaxis. Frontiers in Immunology 8: 1323-1323, 2017

Role of Rac 1 and cAMP in endothelial barrier stabilization and thrombin-induced barrier breakdown. Journal of Cellular Physiology 220(3): 716-726, 2009

Intermedin (adrenomedullin2) stabilizes the endothelial barrier and antagonizes thrombin-induced barrier failure in endothelial cell monolayers. British Journal of Pharmacology 165(1): 208-222, 2012

Involvement of the H1 Histamine Receptor, p38 MAP Kinase, Myosin Light Chains Kinase, and Rho/ROCK in Histamine-Induced Endothelial Barrier Dysfunction. Microcirculation 22(4): 237-248, 2016

Intracellular regulation of thrombin induced endothelial cell barrier dysfunction. American Review of Respiratory Disease 145(4 PART 2): A837, 1992

ROCK mediates thrombin's endothelial barrier dysfunction. American Journal of Physiology. Cell Physiology 279(1): C195-C204, 2000

Involvement of p38 map kinase and caldesmon in thrombin-induced endothelial cell barrier dysfunction. FASEB Journal 16(4): A442, March 20, 2002

Role of CaM kinase II and ERK activation in thrombin-induced endothelial cell barrier dysfunction. American Journal of Physiology. Lung Cellular and Molecular Physiology 285(1): L43-L54, 2003

Mechanisms of cholera toxin prevention of thrombin- and PMA-induced endothelial cell barrier dysfunction. Microvascular Research 48(2): 212-235, 1994

Novel role of microtubules in thrombin-induced endothelial barrier dysfunction. Faseb Journal 18(15): 1879-1890, 2004

cAMP controls the restoration of endothelial barrier function after thrombin-induced hyperpermeability via Rac1 activation. Physiological Reports 2(10): -, 2014

ERK MAP kinase is involved in thrombin-mediated endothelial cell barrier dysfunction. FASEB Journal 15(4): A111, March 7, 2001

The role of vinculin and talin phosphorylation in thrombin-induced endothelial barrier dysfunction. Clinical Research 41(2): 138A, 1993

Pharmacological inhibition of HDAC6 attenuates endothelial barrier dysfunction induced by thrombin. Biochemical and Biophysical Research Communications 408(4): 630-634, 2011

Extracellular ATP opposes thrombin-induced myosin light chain phosphorylation and loss of barrier integrity in corneal endothelial cells. Experimental Eye Research 81(2): 183-192, 2005